BIMI International Medical Inc. (BIMI)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 5.45 Million USD | -58.14% |
| 2021 | 13.03 Million USD | 158.94% |
| 2020 | 5.03 Million USD | 4587.33% |
| 2019 | 107.38 Thousand USD | -98.15% |
| 2018 | 5.81 Million USD | -19.47% |
| 2017 | 7.22 Million USD | 25.4% |
| 2016 | 5.76 Million USD | -28.51% |
| 2015 | 8.05 Million USD | -19.02% |
| 2014 | 9.95 Million USD | 18.89% |
| 2013 | 8.36 Million USD | -16.77% |
| 2012 | 10.05 Million USD | 2.7% |
| 2011 | 9.79 Million USD | 234.01% |
| 2010 | 2.93 Million USD | 569.37% |
| 2009 | 437.91 Thousand USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 400 Thousand USD | -3.5% |
| 2004 | 414.5 Thousand USD | 151.98% |
| 2003 | 164.5 Thousand USD | 9.67% |
| 2002 | 150 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q3 | 4.47 Million USD | 0.95% |
| 2023 Q1 | 5.17 Million USD | -5.06% |
| 2023 Q2 | 4.42 Million USD | -14.51% |
| 2022 Q3 | 12.61 Million USD | -5.53% |
| 2022 Q2 | 13.35 Million USD | 0.48% |
| 2022 FY | 5.45 Million USD | -58.14% |
| 2022 Q4 | 5.45 Million USD | -56.76% |
| 2022 Q1 | 13.29 Million USD | 1.98% |
| 2021 Q3 | 11.39 Million USD | -8.58% |
| 2021 FY | 13.03 Million USD | 158.94% |
| 2021 Q1 | 9.16 Million USD | 82.03% |
| 2021 Q2 | 12.46 Million USD | 36.01% |
| 2021 Q4 | 13.03 Million USD | 14.4% |
| 2020 Q3 | 4.8 Million USD | -5.21% |
| 2020 Q4 | 5.03 Million USD | 4.72% |
| 2020 Q2 | 5.07 Million USD | 203.74% |
| 2020 Q1 | 1.66 Million USD | 1454.53% |
| 2020 FY | 5.03 Million USD | 4587.33% |
| 2019 Q1 | 5.94 Million USD | 2.12% |
| 2019 FY | 107.38 Thousand USD | -98.15% |
| 2019 Q4 | 107.38 Thousand USD | -98.1% |
| 2019 Q3 | 5.65 Million USD | -2.76% |
| 2019 Q2 | 5.81 Million USD | -2.08% |
| 2018 Q1 | 6.36 Million USD | -11.83% |
| 2018 Q2 | 6.79 Million USD | 6.74% |
| 2018 FY | 5.81 Million USD | -19.47% |
| 2018 Q3 | 5.82 Million USD | -14.31% |
| 2018 Q4 | 5.81 Million USD | -0.14% |
| 2017 Q2 | 5.9 Million USD | 1.68% |
| 2017 Q1 | 5.8 Million USD | 0.77% |
| 2017 Q3 | 6.01 Million USD | 1.84% |
| 2017 Q4 | 7.22 Million USD | 20.17% |
| 2017 FY | 7.22 Million USD | 25.4% |
| 2016 Q1 | 6.2 Million USD | -23.01% |
| 2016 FY | 5.76 Million USD | -28.51% |
| 2016 Q2 | 6.07 Million USD | -2.09% |
| 2016 Q3 | 6.05 Million USD | -0.39% |
| 2016 Q4 | 5.76 Million USD | -4.78% |
| 2015 Q4 | 8.05 Million USD | 24.87% |
| 2015 Q3 | 6.45 Million USD | -24.37% |
| 2015 FY | 8.05 Million USD | -19.02% |
| 2015 Q2 | 8.53 Million USD | 6.02% |
| 2015 Q1 | 8.04 Million USD | -19.12% |
| 2014 Q2 | 8.43 Million USD | -0.2% |
| 2014 Q4 | 9.95 Million USD | 10.9% |
| 2014 Q1 | 8.45 Million USD | 0.98% |
| 2014 FY | 9.95 Million USD | 18.89% |
| 2014 Q3 | 8.97 Million USD | 6.38% |
| 2013 Q2 | 9.83 Million USD | 20.06% |
| 2013 Q3 | 9.09 Million USD | -7.53% |
| 2013 Q4 | 8.36 Million USD | -8.0% |
| 2013 FY | 8.36 Million USD | -16.77% |
| 2013 Q1 | 8.19 Million USD | -18.5% |
| 2012 Q1 | 10.62 Million USD | 8.48% |
| 2012 Q3 | 11.46 Million USD | 16.49% |
| 2012 Q2 | 9.84 Million USD | -7.3% |
| 2012 FY | 10.05 Million USD | 2.7% |
| 2012 Q4 | 10.05 Million USD | -12.33% |
| 2011 Q3 | 5.69 Million USD | -1.01% |
| 2011 FY | 9.79 Million USD | 234.01% |
| 2011 Q4 | 9.79 Million USD | 71.94% |
| 2011 Q2 | 5.75 Million USD | -2.01% |
| 2011 Q1 | 5.87 Million USD | 100.26% |
| 2010 Q3 | 1.16 Million USD | -32.12% |
| 2010 Q1 | 1.22 Million USD | 178.89% |
| 2010 Q4 | 2.93 Million USD | 150.95% |
| 2010 FY | 2.93 Million USD | 569.37% |
| 2010 Q2 | 1.72 Million USD | 40.9% |
| 2009 FY | 437.91 Thousand USD | 0.0% |
| 2009 Q2 | 671.4 Thousand USD | 0.0% |
| 2009 Q3 | 1.25 Million USD | 87.1% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q4 | 437.91 Thousand USD | -65.14% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 Q1 | 6500.00 USD | -98.38% |
| 2006 Q2 | 31.5 Thousand USD | 384.62% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | -100.0% |
| 2006 FY | - USD | -100.0% |
| 2005 Q1 | 400 Thousand USD | -3.5% |
| 2005 Q4 | 400 Thousand USD | 0.0% |
| 2005 Q2 | 400 Thousand USD | 0.0% |
| 2005 Q3 | 400 Thousand USD | 0.0% |
| 2005 FY | 400 Thousand USD | -3.5% |
| 2004 Q3 | 564.5 Thousand USD | 243.16% |
| 2004 FY | 414.5 Thousand USD | 151.98% |
| 2004 Q2 | 164.5 Thousand USD | 0.0% |
| 2004 Q4 | 414.5 Thousand USD | -26.57% |
| 2004 Q1 | 164.5 Thousand USD | 0.0% |
| 2003 FY | 164.5 Thousand USD | 9.67% |
| 2003 Q3 | 7000.00 USD | 0.0% |
| 2003 Q4 | 164.5 Thousand USD | 2250.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | -100.0% |
| 2002 FY | 150 Thousand USD | 0.0% |
| 2002 Q4 | 150 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 1.32 Million USD | -313.262% |
| China Jo-Jo Drugstores, Inc. | 43.21 Million USD | 87.378% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 190.5 Million USD | 97.136% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 183.17 Million USD | 97.022% |
| Leafly Holdings, Inc. | 29.08 Million USD | 81.243% |
| Leafly Holdings, Inc. | 29.08 Million USD | 81.243% |
| LifeMD, Inc. | 18.93 Million USD | 71.185% |
| LifeMD, Inc. | 18.93 Million USD | 71.185% |
| TRxADE HEALTH, Inc. | 7.1 Million USD | 23.206% |
| PetMed Express, Inc. | 1.45 Million USD | -275.195% |
| Walgreens Boots Alliance, Inc. | 9.55 Billion USD | 99.943% |